🔎 Trials Near Me

መነሻ › HIV › Texas

በTexas ለHIV የሚደረጉ ክሊኒካዊ ጥናቶች

ለHIV የሚደረጉ 23 ጥናቶች በTexas ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።

በTexas ውስጥ ያሉ ከተሞች

Official study text (English)

Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention

  • Abounding Prosperity Inc., Dallas
  • Prism Health, Dallas
  • UT Health, Houston
  • እና 1 ተጨማሪ
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT07473778

A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed

  • GSK Investigational Site, Austin
  • GSK Investigational Site, Dallas
  • GSK Investigational Site, Dallas
  • እና 2 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 12 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT07650916

ADELANTE: A Randomized Controlled Trial to Improve Engagement in Care for Latinos With HIV

  • Baylor College of Medicine, Houston
ተሳታዮችን በመፈለግ ላይ
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT06274632

A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)

  • Saint Hope Foundation, Inc. ( Site 1504), Bellaire
  • Prism Health North Texas, Oak Cliff Health Center ( Site 1514), Dallas
  • Texas Center for Infectious Disease Associates ( Site 1502), Fort Worth
  • እና 1 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 2/3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ21 ሴፕቴ 2026 · NCT07266831

Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission

  • 5128, Baylor College of Medicine/Texas Children's Hospital Clinical Research Site, Houston
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
48 Hours · ሁሉም ጾታዎች · የተሻሻለው በ9 ሴፕቴ 2026 · NCT02140255

Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus

  • M D Anderson Cancer Center, Houston
ተሳታዮችን በመፈለግ ላይደረጃ 2
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ4 ሴፕቴ 2026 · NCT02479698

A Clinical Trial to Look at the Safety and Immune Responses of the RNA-based Vaccine BNT168 in Adults Living With or Without HIV

  • The Crofoot Research Center, Houston
ተሳታዮችን በመፈለግ ላይደረጃ 1ጤናማ ተሳታዮች ይቀበላሉ
እድሜ ከ18 እስከ 50 · ሁሉም ጾታዎች · የተሻሻለው በ21 ኦገስ 2026 · NCT07698600

Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study

  • University of Texas M.D. Anderson Cancer Center, Houston
ተሳታዮችን በመፈለግ ላይ
እድሜ ከ45 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ19 ኦገስ 2026 · NCT04949464

Positive Peers Intervention Clinical Trial

  • Thomas Street Clinic, Houston
ተሳታዮችን በመፈለግ ላይ
እድሜ ከ13 እስከ 34 · ሁሉም ጾታዎች · የተሻሻለው በ18 ኦገስ 2026 · NCT06388109

Screen2Prevent (S2P)

  • Baylor College of Medicine, Houston
ተሳታዮችን በመፈለግ ላይጤናማ ተሳታዮች ይቀበላሉ
እድሜ ከ14 እስከ 24 · ሁሉም ጾታዎች · የተሻሻለው በ17 ኦገስ 2026 · NCT07728123

Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy

  • North Texas Infectious Diseases Consultants, P.A., Dallas
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ14 ኦገስ 2026 · NCT07682961

First Time in Human Study of Long Acting VH4524184 Formulations

  • GSK Investigational Site, San Antonio
ተሳታዮችን በመፈለግ ላይደረጃ 1ጤናማ ተሳታዮች ይቀበላሉ
እድሜ ከ18 እስከ 55 · ሁሉም ጾታዎች · የተሻሻለው በ10 ኦገስ 2026 · NCT06310551

A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV

  • UT Health Houston, Houston
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ30 ጁላይ 2026 · NCT07143968

A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)

  • GSK Investigational Site, Bellaire
  • GSK Investigational Site, Dallas
  • GSK Investigational Site, Houston
  • እና 2 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ23 ጁላይ 2026 · NCT07202546

Kidney Transplantation From Donors With HIV: Impact on Rejection and Long-Term Outcomes (Expanding HOPE Kidney)

  • Houston Methodist Research Institute, Houston
ተሳታዮችን በመፈለግ ላይ
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ጁን 2026 · NCT06263426

Menopausal HT for Women Living With HIV (HoT)

  • Houston AIDS Research Team CRS (31473), Houston
ተሳታዮችን በመፈለግ ላይደረጃ 4
እድሜ ከ40 እስከ 60 · ሴቶች · የተሻሻለው በ22 ሜይ 2026 · NCT06856174

Assessing the Use of MY-RIDE, a Just-in-time Adaptive Intervention, to Improve HIV Prevention and Substance Use in Youth Experiencing Homelessness

  • The University of Texas Health Science Center at Houston, Houston
ተሳታዮችን በመፈለግ ላይ
እድሜ ከ18 እስከ 25 · ሁሉም ጾታዎች · የተሻሻለው በ13 ሜይ 2026 · NCT06074354

HIV+ Deceased Donor Heart Transplant Study for HIV+ Recipients

  • UT Southwestern Medical Center, Dallas
ተሳታዮችን በመፈለግ ላይ
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ21 ጃንዩ 2026 · NCT06659952

The Unlocking PrEP Study: Integration of Peer Health Navigation Into Comprehensive Re-entry Services

  • UT Southwestern Medical Center, Dallas
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
እድሜ ከ18 እስከ 99 · ሁሉም ጾታዎች · የተሻሻለው በ15 ጃንዩ 2026 · NCT07292792

A Study to Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting Cabotegravir Plus Recombinant Human Hyaluronidase PH20 in Healthy Adult Participants

  • GSK Investigational Site, Austin
ተሳታዮችን በመፈለግ ላይደረጃ 1ጤናማ ተሳታዮች ይቀበላሉ
እድሜ ከ18 እስከ 55 · ሁሉም ጾታዎች · የተሻሻለው በ18 ዲሴም 2025 · NCT05418868

Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)

  • UT Health Houston, Houston
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 40 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ዲሴም 2025 · NCT05488431

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of VH4011499 Compared to Placebo in Adults Without HIV

  • GSK Investigational Site, Austin
ተሳታዮችን በመፈለግ ላይደረጃ 1ጤናማ ተሳታዮች ይቀበላሉ
እድሜ ከ18 እስከ 55 · ሁሉም ጾታዎች · የተሻሻለው በ29 ኦክቶ 2025 · NCT06724640

Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics

  • GSK Investigational Site, Houston
  • GSK Investigational Site, Houston
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ ከ6 እስከ 12 · ሁሉም ጾታዎች · የተሻሻለው በ19 ሴፕቴ 2024 · NCT05674656

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።